- Home
- APGE vs VNT Comparison
APGE vs VNT Comparison
Compare APGE & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | VNT |
|---|---|---|
| Founded | 2022 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | APGE | VNT |
|---|---|---|
| Price | $134.08 | $30.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $109.67 | $46.89 |
| AVG Volume (30 Days) | ★ 5.4M | 1.6M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ 0.36 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $3,075,600,000.00 |
| Revenue This Year | N/A | $2.39 |
| Revenue Next Year | N/A | $4.19 |
| P/E Ratio | ★ N/A | $45.83 |
| Revenue Growth | N/A | ★ 3.24 |
| 52 Week Low | $34.34 | $27.25 |
| 52 Week High | $134.35 | $48.20 |
Technical Indicators
Market Signals| Indicator | APGE | VNT |
|---|---|---|
| Relative Strength Index (RSI) | 80.75 | 55.17 |
| Support Level | $80.52 | $27.72 |
| Resistance Level | N/A | $31.26 |
| Average True Range (ATR) | 0.43 | 0.81 |
| MACD | -1.69 | 0.16 |
| Stochastic Oscillator | 86.53 | 70.67 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About VNT Vontier Corporation
Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3.1 billion in sales in 2025.